Author: Aron Solomon

A Pulitzer Prize-nominated writer, Aron Solomon, JD, is the Chief Strategy Officer for AMPLIFY. He has taught entrepreneurship at McGill University and the University of Pennsylvania, and was elected to Fastcase 50, recognizing the top 50 legal innovators in the world. Aron has been featured in Newsweek, The Hill, Fast Company, Fortune, Forbes, CBS News, CNBC, USA Today, ESPN, TechCrunch, BuzzFeed, Venture Beat, The Independent, Fortune China, Abogados, Today’s Esquire, Yahoo!, ABA Journal, Law.com, The Boston Globe, and many other leading publications across the globe. 

By Staff Writer Following more than 3 months of testimony, the prosecution and defense rested on Wednesday in the Elizabeth Holmes trial. With closing arguments expected to begin late next week, the trial that began in August is entering its final phase before Holmes’ fate is deliberated by the jurors. NBC Bay Area reporter Scott Budman spoke with Esquire Digital’s chief legal analyst, Aron Solomon, who stated: “Since she’s been on the stand, what she’s saying and the way she’s saying it, at times resonates with the jury and at times, isn’t going to resonate with the jury. So, it…

Read More

By Staff Writer On Wednesday, the Supreme Court heard oral arguments in Dobbs v Jackson Women’s Health Organization, one of the most important cases to come before the Court in a generation, which has the potential to overturn Roe v Wade and have a nationwide impact on women’s reproductive rights. According to Aron Solomon, chief legal analyst for Esquire Digital, who has extensively provided commentary on Dobbs, “In a detailed and spirited oral argument today, lawyers for both sides ran up against the brick wall that is stare decisis (the legal concept that we should stand by things already decided). …

Read More

By Staff Writer Day two of Elizabeth Holmes testimony began yesterday, and NBC Bay Area’s Scott Budman was on the scene to report as close to 100 people began lining up in the wee hours of the morning, hoping to get a seat inside the Elizabeth Holmes trial. According to Budman, Holmes told the jury that Theranos had several small victories in the early days, including constructive talks with the Department of Defense and several large pharmaceutical companies. According to Aron Solomon, chief legal analyst for Esquire Digital: “This is going to get super, super complicated, very, very soon.” Partly…

Read More

By Staff Writer On Monday morning, Aron Solomon, chief legal analyst for Esquire Digital, joined anchor Ken Buffa on Cheddar’s Opening Bell to discuss the surprising decision for Theranos founder Elizabeth Holmes to take the stand and testify on her own-behalf late last week. Watch the clip now, or read the full transcript below! Buffa: “In a surprise turn of events, Elizabeth Holmes took the stand in her own defense on Friday and will be back to testify later today. Holmes, who started the blood testing start-up Theranos back in 2003, faces 11 counts of wire fraud, as well as…

Read More

By Aron Solomon The WTA finals wrapped up on Wednesday, with Garbiñe Muguruza taking home the championship trophy. It was the first time a Spanish woman has ever hoisted the WTA finals trophy. The 28-year-old’s win over Estonian Anett Kontaveit – who had the true breakout year among all WTA competitors – was memorable and historic, putting the finishing touches on one of the best tour final tournaments ever. The level of tennis throughout the entire week was absolutely amazing, with riveting matches and a high level of play befitting this new group of the world’s top players. While anyone…

Read More

By Staff Writer On Thursday, NBC Bay Area’s Scott Budman reported that the prosecution in the Elizabeth Holmes trial started the day by focusing on the faulty Theranos testing machines. Jurors listened intently to powerful testimony as Erin Tompkins of Arizona explained how she was told by a Theranos test that she had tested positive for HIV antibodies, which she later found out was incorrect. Another witness, Dr. Mark Burnes, testified about one of his patients that took a Theranos test, which wrongly detected prostate cancer. Esquire Digital’s chief legal analyst, Aron Solomon, commented: “This is going to resonate far…

Read More

By Rev. Markel Hutchins Editor’s Note: This article originally appeared on Inside Sources When navigating the present and charting the future, it is critical to be informed by the past. In this way, a racially just United States requires a deep examination of how centuries of racial inequities have propelled injustices in our nation’s economic, criminal justice, educational, and health care systems. However, those who viscerally advocate “Critical Race Theory” (CRT) – an inelegant term for a movement that declares that race is exclusively at the heart of all social interactions and structures – also risk overlooking the past when it…

Read More

By Staff Writer NBC Bay Area reporter Scott Budman returned to the San Jose courthouse on Monday to continue his extensive and in-depth coverage of the Elizabeth Holmes trial, which was back in session following a week of setbacks. Houston investor Alan Eisenmen, who along with his family, invested almost $1.2 million in Theranos in 2006, and an additional $100,000 in 2013, took the stand to testify that he repeatedly requested more information from Theranos than what they were sharing with investors as a whole. According to Eisenman, he initially invested in Theranos at $3 per share, saw their value…

Read More